🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT04391465
Recruiting Not applicable

Assessment of the Relationship Between Cerebral Blood Flow and Heart Rate

NCT04391465 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2021-08-11
Last updated
2026-05-07

Condition(s) studied

Cerebrovascular CirculationPhysiology

Investigational drug(s) / intervention(s)

Electrophysiological Pacing

Electrophysiological Pacing: Assess the MCA CBF velocity response at different paced heart rates.

Study summary

The investigators will seek to determine the relationship between heart rate and middle cerebral artery (MCA) cerebral blood flow (CBF), as well as better understand the hemodynamic determinants of MCA CBF velocity. In order to manipulate heart rate, the investigators will recruit patients already scheduled for clinically indicated elective electrophysiological studies, where temporary pacing catheters placed in the right atrium can be used to artificially pace the heart at controlled rates. MCA CBF will be measured by transcranial Doppler ultrasound.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Male or female * Age 18-70 years, inclusive * Scheduled for clinically indicated elective electrophysiological studies where temporary pacing catheters are being placed in the right atrium * Left ventricular ejection fraction ≥50% * Able and willing to provide informed consent * Able to travel to the Cardiac Electrophysiology Laboratory at the Foothills Medical Centre, Calgary, Alberta, Canada Exclusion Criteria: * Unable or unwilling to provide informed consent * Other factors which in the investigator's opinion would prevent the participant from completing the protocol

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Foothills Medical Center Calgary Alberta Recruiting

More University of Calgary trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04391465 on ClinicalTrials.gov ↗ ← All trials in Canada